Skip to main content
Loading market data...
ETF Cboe BZX USD

Franklin Genomic Advancements ETF HELX

Issuer: Franklin Templeton SEC registrant: Franklin Templeton ETF Trust Equity · US
Last price 41.66 USD Change: Unchanged 0.00 Percent change: Unchanged 0.00%

Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed

Expense ratio
0.50%
Prospectus 1 Aug 2025
Net assets
$27.9M
As of 30 Jun 2026
Holdings
63
As of 30 Jun 2026
12-month distribution yield
0.34%
Irregular
Asset class
Equity
From holdings

Franklin Genomic Advancements ETF (HELX) is an exchange-traded fund listed on Cboe BZX in the United States, issued by Franklin Templeton. Its category is Equity · US (equity). Its last price was US$41.66 on 20 Oct 2026. Its expense ratio is 0.5% a year, from its prospectus dated 1 Aug 2025. It reported net assets of US$27.94 million as of 30 Jun 2026. Its latest holdings report lists 63 holdings as of 30 Jun 2026. Over the last 12 months it paid distributions of US$0.14 a unit, a 12-month distribution yield of 0.34%.

General information only: nothing on TakeProfits takes into account your objectives, financial situation or needs, and it isn't personal financial advice or a recommendation to buy or sell anything. Consider whether it suits you and get advice from a licensed adviser before acting. Market data may be delayed and comes from third-party sources.

Fees

Total annual operating expenses (gross)
0.50%
Net, after fee waivers or reimbursements
No waiver stated
Management fee
0.50%
Prospectus date
1 Aug 2025
Filed with the SEC
28 Jul 2025

Size and reporting

Net assets
$27,936,547
Total assets
$27,946,260
Holdings as of
30 Jun 2026
Report made public
27 Aug 2026 (58 days after the month end)

Net assets are for the whole fund series, which for some funds (Vanguard's, for example) also includes mutual fund share classes.

Top holdings

Largest 25 of 63 positions, as of 30 Jun 2026. Weight is the percent of net assets the fund reported.

HELX top holdings as of 30 Jun 2026
# Holding Identifier Weight Value (USD) Type Country Currency
1 GUARDANT HEALTH INC GUARDANT HEALTH INC COM US40131M1099 9.09% $2.5M Equity (common) United States USD
2 NATERA INC NATERA INC COM US6323071042 7.46% $2.1M Equity (common) United States USD
3 KRYSTAL BIOTECH INC KRYSTAL BIOTECH INC COM US5011471027 6.33% $1.8M Equity (common) United States USD
4 LIGAND PHARMACEUTICALS INC LIGAND PHARMACEUTICALS INC COM NEW US53220K5048 4.62% $1.3M Equity (common) United States USD
5 ADAPTIVE BIOTECHNOLOGIES CORP ADAPTIVE BIOTECHNOLOGIES CORP COM US00650F1093 3.99% $1.1M Equity (common) United States USD
6 UNITED THERAPEUTICS CORP UNITED THERAPEUTICS CORP COM US91307C1027 3.51% $980K Equity (common) United States USD
7 BRIDGEBIO PHARMA INC BRIDGEBIO PHARMA INC COM US10806X1028 3.50% $978K Equity (common) United States USD
8 ELI LILLY & COMPANY ELI LILLY & COMPANY COM US5324571083 2.95% $825K Equity (common) United States USD
9 TWIST BIOSCIENCE CORP TWIST BIOSCIENCE CORP COM US90184D1000 2.85% $796K Equity (common) United States USD
10 VERTEX PHARMACEUTICALS INC VERTEX PHARMACEUTICALS INC COM US92532F1003 2.75% $767K Equity (common) United States USD
11 ASTRAZENECA PLC ASTRAZENECA PLC ORD USD0.25 GB0009895292 2.70% $754K Equity (common) United Kingdom USD
12 TRAVERE THERAPEUTICS INC TRAVERE THERAPEUTICS INC COM US89422G1076 2.59% $724K Equity (common) United States USD
13 INSMED INC INSMED INC COM PAR $.01 US4576693075 2.44% $681K Equity (common) United States USD
14 SAMSUNG BIOLOGICS CO LTD SAMSUNG BIOLOGICS CO LTD KRW2500 KR7207940008 2.26% $630K Equity (common) South Korea KRW
15 CORTEVA INC CORTEVA INC COM US22052L1044 2.25% $630K Equity (common) United States USD
16 MEDPACE HOLDINGS INC MEDPACE HOLDINGS INC COM US58506Q1094 2.15% $600K Equity (common) United States USD
17 ALNYLAM PHARMACEUTICALS INC ALNYLAM PHARMACEUTICALS INC COM US02043Q1076 1.96% $547K Equity (common) United States USD
18 TEMPUS AI INC TEMPUS AI INC CL A US88023B1035 1.95% $544K Equity (common) United States USD
19 IONIS PHARMACEUTICALS INC IONIS PHARMACEUTICALS INC COM US4622221004 1.91% $534K Equity (common) United States USD
20 NEUROCRINE BIOSCIENCES INC NEUROCRINE BIOSCIENCES INC COM US64125C1099 1.84% $515K Equity (common) United States USD
21 REGENERON PHARMACEUTICALS INC REGENERON PHARMACEUTICALS INC COM US75886F1075 1.80% $502K Equity (common) United States USD
22 VERACYTE INC VERACYTE INC COM US92337F1075 1.64% $459K Equity (common) United States USD
23 ARGENX SE ARGENX SE EUR0.10 NL0010832176 1.64% $458K Equity (common) Netherlands EUR
24 PTC THERAPEUTICS INC PTC THERAPEUTICS INC COM US69366J2006 1.46% $409K Equity (common) United States USD
25 BIONTECH SE BIONTECH SE SPONSORED ADS US09075V1026 1.38% $387K Equity (common) Germany USD

Breakdowns

Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.

Asset type

Asset type by weight
TypeWeightBar
Equity (common) 97.88%
Equity (preferred) 0.85%

Country

Country by weight
CountryWeightBar
United States 86.61%
United Kingdom 3.04%
South Korea 2.63%
Germany 2.23%
Netherlands 2.12%
Switzerland 1.21%
Ireland 0.78%
Singapore 0.10%

Currency exposure

Currency exposure by weight
CurrencyWeightBar
US dollar (USD) 93.61%
South Korean won (KRW) 2.63%
Euro (EUR) 2.49%

Sector

Sector weights for holdings matched to listed stocks
SectorWeightBar
Health Care 60.93%
Technology 3.62%
Consumer Staples 2.25%
Industrials 2.17%
Health Technology 0.77%

Source: SEC Form N-PORT (opens in a new tab) Holdings as of

Distributions

Paid in the last 12 months
$0.1430
1 payment per unit
12-month yield
0.34%
Distributions only, not total return
Frequency
Irregular
From the gaps between ex-dates
Latest ex-date
30 Dec 2025

12-month yield = distributions per unit with an ex-date in the last 12 months ($0.1430) ÷ latest price ($41.66) × 100 = 0.34%. It looks back, so it is not a forecast; special distributions in the window are included.

Why a distribution yield is not the fund's return: yield vs total return

Distribution history table (3 payments)
HELX distributions per unit by ex-date
Ex-dateAmount per unit
30 Dec 2025$0.1430
30 Dec 2021$0.0040
13 Dec 2021$0.1140

Filings and sources

Compare with

Largest funds in the same category:

Up to four symbols separated by commas. ASX funds end in .AX, for example IVV.AX.

How ETF overlap is measured, with a worked example

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.

Catalyst evidence

Loading…

Loading evidence…

Supporting sources

    Skip to main content

    All resources and tools

    Market ticker

    Markets

    Research

    Tools

    My investments

    Account

    Region and currency

    Colour theme